MAGEA1
melanoma antigen family A, 1 (directs expression of antigen MZ2-E)
MAGEA1; melanoma antigen family A, 1 (directs expression of antigen MZ2-E); MAGE1; melanoma-associated antigen 1; cancer/testis antigen family 1; member 1; CT1.1; melanoma antigen family A 1; melanoma antigen MAGE 1; melanoma associated antigen 1; melanoma associated antigen MZ2 E; MGC9326; antigen MZ2-E; MAGE-1 antigen; melanoma antigen MAGE-1; cancer/testis antigen 1.1; melanoma-associated antigen MZ2-E; cancer/testis antigen family 1, member 1;
MAGEA3
melanoma antigen family A, 3
MAGEA3; melanoma antigen family A, 3; MAGE3; melanoma-associated antigen 3; antigen MZ2 D; cancer/testis antigen family 1; member 3; CT1.3; HIP8; HYPD; MAGE 3 antigen; melanoma associated antigen 3; MGC14613; MGC1461; MAGEA6; Melanoma antigen family A 3; antigen MZ2-D; MAGE-3 antigen; cancer/testis antigen 1.3; cancer/testis antigen family 1, member 3;
MAGEA4
melanoma antigen family A, 4
MAGEA4; melanoma antigen family A, 4; MAGE4; melanoma-associated antigen 4; cancer/testis antigen family 1; member 4; CT1.4; MAGE 41; MAGE X2; MAGE4A; MAGE4B; melanoma associated antigen 4; MGC21336; MAGE-4 antigen; MAGE-41 antigen; MAGE-X2 antigen; cance;
MCAM
melanoma cell adhesion molecule
MCAM; melanoma cell adhesion molecule; cell surface glycoprotein MUC18; CD146; Gicerin; MUC18; melanoma adhesion molecule; cell surface glycoprotein P1H12; melanoma-associated antigen A32; melanoma-associated antigen MUC18; S-endo 1 endothelial-associated antigen;
MIA
melanoma inhibitory activity
MIA; melanoma inhibitory activity; melanoma-derived growth regulatory protein; CD RAP; CD-RAP;
MIA2
melanoma inhibitory activity 2
MIA2; melanoma inhibitory activity 2; melanoma inhibitory activity protein 2; FLJ22404; MIA2_HUMAN;
MAGEB18
melanoma antigen family B, 18
MAGEB18; melanoma antigen family B, 18; melanoma-associated antigen B18; MGC33889; B430216B18Rik; MAGBI_HUMAN; MAGE-B18 antigen; MAGEB18 antigen; MGC114496; RGD1560369; RP23-289C5.3;
MAGEA11
melanoma antigen family A, 11
MAGEA11; melanoma antigen family A, 11; MAGE11; melanoma-associated antigen 11; cancer/testis antigen family 1; member 11; CT1.11; MAGE 11; MAGE 11 antigen; MAGEA 11; melanoma associated antigen 11; MGC10511; MAGE-11 antigen; cancer/testis antigen 1.11; c;
MAGEA2
melanoma antigen family A, 2
MAGEA2; melanoma antigen family A, 2; MAGE2; melanoma-associated antigen 2; cancer/testis antigen family 1; member 2; CT1.2; MAGEA2A; MAGE-2 antigen; melanoma antigen 2; cancer/testis antigen 1.2; cancer/testis antigen family 1, member 2; MAGEA2B; MGC1319;
MAGEA8
melanoma antigen family A, 8
MAGEA8; melanoma antigen family A, 8; MAGE8; melanoma-associated antigen 8; cancer/testis antigen family 1; member 8; CT1.8; MAGE 8 antigen; MGC2182; MAGE8 antigen; Melanoma antigen family A 8; Melanoma associated antigen 8; MAGE-8 antigen; OTTHUMP00000024218; cancer/testis antigen 1.8; cancer/testis antigen family 1, member 8;
MAGEA9
melanoma antigen family A, 9
MAGEA9; melanoma antigen family A, 9; MAGE9; melanoma-associated antigen 9; cancer/testis antigen family 1; member 9; CT1.9; MAGE 9 antigen; melanoma associated antigen 9; MGC8421; MAGE-9 antigen; cancer/testis antigen 1.9; cancer/testis antigen family 1,;
MAGEB1
melanoma antigen family B, 1
MAGEB1; melanoma antigen family B, 1; melanoma-associated antigen B1; cancer/testis antigen family 3; member 1; CT3.1; DAM10; DSS/AHC critical interval MAGE superfamily 10; MAGE Xp; MAGEL1; MGC9322; Cancer/testis antigen 3.1; DSS AHC critical interval MAGE superfamily 10; MAGE B1 antigen; MAGEXP antigen; Melanoma associated antigen B1; MAGE-B1 antigen; MAGE-XP antigen; cancer/testis antigen family 3, member 1; DSS-AHC critical interval MAGE superfamily 10; MAGE-Xp;
MAGEB6
melanoma antigen family B, 6
MAGEB6; melanoma antigen family B, 6; melanoma-associated antigen B6; cancer/testis antigen family 3; member 4; CT3.4; FLJ40242; MAGE B6; MAGEB6A; Cancer/testis antigen 3.4; MAGEB6 antigen; Melanoma associated antigen B6; MAGE-B6 antigen; cancer/testis antigen family 3, member 4; MAGE-B6;
MAGED1
Maged1 melanoma antigen, family D, 1
MAGED1; melanoma antigen, family D, 1; melanoma-associated antigen D1; MAGE-D1 antigen; neurotrophin receptor-interacting MAGE homolog; NRAGE; Dlixin; Dlxin1; Dlxin-1; mFLJ00163; DXBwg1492e; 2810433C11Rik; 5430405L04Rik; FLJ00163;
MAGED2
melanoma antigen family D, 2
MAGED2; melanoma antigen family D, 2; melanoma-associated antigen D2; 11B6; BCG1; breast cancer associated gene 1; HCA10; hepatocellular carcinoma associated protein; hepatocellular carcinoma associated protein HCA10; JCL 1; MAGE D2; MAGED; melanoma assoc;
MAGEH1
melanoma antigen family H, 1
MAGEH1; melanoma antigen family H, 1; melanoma-associated antigen H1; APR1; restin; MAGE-H1 antigen; apoptosis-related protein 1; melanoma antigen, family H, 1 protein; APR-1; MAGEH;
MFI2
antigen p97 (melanoma associated) identified
MFI2; antigen p97 (melanoma associated) identified; melanotransferrin; CD228; FLJ38863; MAP97; membrane bound transferrin like protein; MGC4856; MTF1; Antigen p97; CD228 antigen; Melanoma associated antigen p97; Melanoma-associated antigen p97; TRFM_HUMAN; membrane-bound transferrin-like protein; melanoma-associated antigen p97, isoform 2;
MAGEA12
melanoma antigen family A, 12
MAGEA12; melanoma antigen family A, 12; MAGE12; melanoma-associated antigen 12; cancer/testis antigen family 1; member 12; CT1.12; MAGE-12 antigen; MAGE12F antigen; cancer/testis antigen 1.12; cancer/testis antigen family 1, member 12;
MAGEC1
melanoma antigen family C, 1
MAGEC1; melanoma antigen family C, 1; melanoma-associated antigen C1; cancer/testis antigen family 7; member 1; CT7; CT7.1; MAGE C1; MGC39366; MAGE-C1 antigen; cancer/testis antigen 7.1; cancer/testis antigen family 7, member 1;
MUM1
melanoma associated antigen (mutated) 1
MUM1; melanoma associated antigen (mutated) 1; PWWP domain-containing protein MUM1; MUM 1; protein expandere; melanoma ubiquitous mutated protein; mutated melanoma-associated antigen 1; MUM-1; EXPAND1; HSPC211; FLJ14868; FLJ22283; MGC131891; MGC163315;
MAGEA6
melanoma antigen family A, 6
MAGEA6; melanoma antigen family A, 6; MAGE6; melanoma-associated antigen 6; cancer/testis antigen family 1; member 6; CT1.6; MAGE 6 antigen; melanoma antigen family A 6; melanoma associated antigen 6; Cancer/testis antigen 1.6; MAGA6_HUMAN; MAGE 3b; MAGE-6 antigen; MAGE3B; MAGE3B antigen; OTTHUMP00000024223; OTTHUMP00000024224; OTTHUMP00000205538; cancer/testis antigen family 1, member 6; MAGE-3b;
AIM1L
absent in melanoma 1-like
AIM1L; absent in melanoma 1-like; beta gamma crystallin domain containing 2; CRYBG2; FLJ38020;
BAGE2
B melanoma antigen family, member 2
BAGE2; B melanoma antigen family, member 2; B melanoma antigen 2; cancer/testis antigen family 2; member 2; CT2.2; cancer/testis antigen 2.2; cancer/testis antigen family 2, member 2;
BAGE3
B melanoma antigen family, member 3
BAGE3; B melanoma antigen family, member 3; B melanoma antigen 3; cancer/testis antigen family 2; member 3; CT2.3; cancer/testis antigen 2.3; cancer/testis antigen family 2, member 3;
BAGE4
B melanoma antigen family, member 4
BAGE4; B melanoma antigen family, member 4; MLL3 pseudogene , MLL3P; B melanoma antigen 4; cancer/testis antigen family 2; member 4; CT2.4; BAGE4_HUMAN; Cancer/testis antigen 2.4; MGC119851; MGC119852; MGC119853; MLL3P; MLL3 pseudogene; cancer/testis antigen family 2, member 4;
MAGEB4
melanoma antigen family B, 4
MAGEB4; melanoma antigen family B, 4; melanoma-associated antigen B4; cancer/testis antigen family 3; member 6; CT3.6; melanoma associated antigen B4; MGC33144; MAGE-B4 antigen; cancer/testis antigen family 3, member 6;
MAGEB3
melanoma antigen family B, 3
MAGEB3; melanoma antigen family B, 3; melanoma-associated antigen B3; cancer/testis antigen family 3; member 5; CT3.5; Cancer/testis antigen family 3 member 5; MAGB3_HUMAN; MAGE B3 antigen; MAGE-B3 antigen; Melanoma associated antigen B3; cancer/testis antigen family 3, member 5;
MAGEA10
melanoma antigen family A, 10
MAGEA10; melanoma antigen family A, 10; MAGE10; melanoma-associated antigen 10; cancer/testis antigen family 1; member 10; CT1.10; MAGE 10 antigen; melanoma associated antigen 10; MGC10599; MAGE-10 antigen; cancer/testis antigen 1.10; cancer/testis antige;
MAGEA5
melanoma antigen family A, 5
MAGEA5; melanoma antigen family A, 5; MAGE5; melanoma-associated antigen 5; cancer/testis antigen family 1; member 5; CT1.5; MAGE 5a antigen; MAGE 5b antigen; MGC129526; Cancer/testis antigen 1.5; Cancer/testis antigen family 1 member 5; MAGE 5 antigen; MAGEA4; Melanoma antigen family A 5; Melanoma associated antigen 5; MAGE-5 antigen; MAGE-5a antigen; MAGE-5b antigen; cancer/testis antigen family 1, member 5;
MAGEB17
melanoma antigen family B, 17
MAGEB17; melanoma antigen family B, 17; melanoma antigen family B, 17 (pseudogene); MAGBH_HUMAN; Melanoma-associated antigen B17;
MAGEB2
melanoma antigen family B, 2
MAGEB2; melanoma antigen family B, 2; melanoma-associated antigen B2; cancer/testis antigen family 3; member 2; CT3.2; DAM6; DSS/AHC critical interval MAGE superfamily 6; MAGE XP 2; melanoma associated antigen B2; MGC26438; MAGE-B2 antigen; MAGE XP-2 anti;
MAGEC2
melanoma antigen family C, 2
MAGEC2; melanoma antigen family C, 2; MAGEE1, melanoma antigen, family E, 1, cancer/testis specific; melanoma-associated antigen C2; cancer/testis antigen 10; CT10; MAGE C2; Cancer testis antigen 10; HCA587; Hepatocellular carcinoma associated antigen 587; Hepatocellular carcinoma-associated antigen 587; MAGC2_HUMAN; MAGE C2 antigen; MAGE E1 antigen; MAGE-C2 antigen; MAGE-E1 antigen; Melanoma associated antigen C2; MGC13377; hepatocellular cancer antigen 587; melanoma antigen, family E, 1, cancer/testis specific; MAGEE1;
MAGEF1
melanoma antigen family F, 1
MAGEF1; melanoma antigen family F, 1; melanoma-associated antigen F1; MAGE-F1 antigen; MGC19617;
MUM1L1
melanoma associated antigen (mutated) 1-like 1
MUM1L1; melanoma associated antigen (mutated) 1-like 1; PWWP domain-containing protein MUM1L1; FLJ33516; MUM1-like protein 1; mutated melanoma-associated antigen 1-like protein 1; MGC129994; MGC129995;
MIA3
melanoma inhibitory activity family, member 3
MIA3; melanoma inhibitory activity family, member 3; melanoma inhibitory activity protein 3; C219 reactive peptide; FLJ39207; KIAA0268; TANGO; UNQ6077; ARNT; C219-reactive peptide; D320; MIA3_HUMAN; RP11-378J18.4; TANGO1; Transport and Golgi organization protein 1;
PRAME
preferentially expressed antigen in melanoma
PRAME; preferentially expressed antigen in melanoma; MAPE; melanoma antigen preferentially expressed in tumors; cancer/testis antigen 130; CT130; 4930534P07Rik; OIP 4; OIP-4; OIP4; OPA interacting protein 4; Opa interacting protein OIP4; OPA-interacting protein 4; PRAME_HUMAN; Preferentially expressed antigen of melanoma; RP23-250F8.3; Opa-interacting protein OIP4;
